The LEO Foundation supports international dermatological research projects and activities that address issues in disease understanding, disease treatment, disease awareness and patient wellbeing. Typical projects and activities are international studies, scientific symposia, science-based knowledge dissemination and awareness campaigns.
The LEO Foundation welcomes applications from projects that:
We prioritise projects that commit to sharing results with the general public, patients and healthcare professionals – for example through publication in peer-reviewed journals, oral presentations and public awareness campaigns.
We also prioritise projects with international scope and we favour projects that are based at a university or university hospital and applicants with solid, well-documented international research backgrounds.
Finally, we also accept applications for support to university-based educational activities within natural sciences that help attract students to medicine, chemistry and pharmacy.
Download the application form inserted below and store it on your own computer.
Fill in the application and send it to firstname.lastname@example.org (you will receive a confirmation that we have received it).
Your application is evaluated by the LEO Foundation Nomination Committee (composed of senior R&D specialists in LEO Pharma and two external specialists).
The committee may wish to contact you in order to discuss your application in greater detail.
The committee selects the most promising applications and prepares recommendations to the board of trustees. The board approves allocation of donations at regular board meetings (see dates below).
When and if approved, your project is assigned a dedicated contact person.
All applicants receive an answer to their applications, sent by e-mail. The Foundation does not provide arguments as to why an application has been rejected.
A list of awarded donations as well as the recipients and project titles is published on this website.
January 5, 2018
March 9, 2018
July 6, 2018
September 21, 2018